Medical Device Priority Approval
On September 22, 2020, CMDE issued a notification that the “Automatic medical PCR analysis system” of Xiamen Zeesan Biotech Co.,Ltd. is proposed to obtain the priority pathway approval, because this product is listed in the national key research and development plan. Priority pathway could accelerate the technical review from CMDE and shorten the registration timeline. Bradynuoen could help evaluate and offer support on priority registration.
